Division of Hematology & Oncology

The Hematology/Oncology Division is devoted to treatment and research in malignant and non-malignant blood disorders, hemostasis and thrombosis, hematopoietic stem cell transplantation and cellular therapeutics, and solid tumor oncology. Our Division has enjoyed continued expansion in faculty and programs during the past several years, accommodating growth and the delivery of care in a rapidly evolving field. Patients at the Medical Center are seen in our outpatient facilities at the Emily Couric Clinical Cancer Center, or in our Community Oncology sites in Fishersville, Culpeper and Charlottesville (Pantops location). We provide comprehensive care on our inpatient ward and stem cell unit, and on the hematology and oncology consultation services.

Division faculty are integral members of the UVA Health System’s Clinical Cancer Center as well as the NCI-designated Cancer Center, directed by Dr. Thomas Loughran, one of 70 such centers in the U.S. The Cancer Center remains in the top 50 US News & World Report rankings, putting us in the top 3% of cancer centers nationally. We are also the only cancer center in Virginia to be listed on Becker’s Hospital Review 100 Hospitals and Health Systems with great oncology programs for six consecutive years.

Our cancer and blood disease multidisciplinary teams apply the latest diagnostic tools and molecular analytics to optimize treatment recommendations. We provide a robust portfolio of clinical trials that bring promising new agents to our patients, including cellular therapy with CAR-T cells for lymphoma and acute lymphoblastic leukemia, and investigational studies of unique bispecific antibody-based cellular therapeutics via the Center for Human Therapeutics. A Sickle Cell Disease program is in place, with a new Adult Comprehensive Bleeding Disorders Center to open in 2019 to complement our long standing excellence in the management of hemostatic and thrombotic disorders.

Our group is committed to providing the best in patient care, education and research, and to improving outcomes for patients with cancer and blood diseases. Please feel free to contact my office if you wish to learn more about our Division or any of our programs.

Michael E. Williams, MD, ScM
Byrd S. Leavell Professor of Medicine
Chief, Hematology/Oncology Division

Experimental Treatment Sends Deadly Leukemia into Remission

Dr. Thomas P. Loughran Jr., director of the University of Virginia Cancer Center, discusses an experimental new treatment approach for a rare, deadly leukemia that can send the disease into remission even in patients for whom the standard therapy has failed, buying them more time to have the stem cell transplant that could save their lives.

Learn More

A UVA Doctor Reflects on Her Work With NASA

NASA astronaut Scott Kelly came home from a yearlong stay on the International Space Station, and a young physician-scientist, Francine Garrett-Bakelman MD, PhD, was waiting anxiously. She had important work to do and only one shot to do it.
Read More

Fellowship Program

UVA fellows obtain clinical training through a combination of ambulatory clinical electives across all aspects of hematology and medical oncology, two inpatient consult services, the inpatient malignant hematology service, and a variety of clinical rotations.
Learn More

Hematology/Oncology Highlights

Notable achievements
See More

Inpatient Hematology and Oncology Moonlighting Information

Links to information and required paperwork for individuals who wish to moonlight.

Find Us On YouTube